Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics

Goicoechea, IbaiPuig, NoemiTeresa Cedena, MariaCordon, LourdesVidriales, Maria-BelenBurgos, LeireFlores-Montero, JuanGutierrez, Norma C.Jose Calasanz, MariaLuisa Martin-Ramos, MariaLara-Astiaso, DavidVilas-Zornoza, AmaiaAlignani, DiegoRodriguez, IdoiaSarvide, SaraiGarcia-Sanz, RamonMartinez-Lopez, JoaquinOriol, AlbertRios, RafaelMartin, JesusMartinez, RafaelSarra, JosepHernandez, Miguel T.De la Rubia, JavierKrsnik, IsabelMaria Moraleda, JosePalomera, LuisBargay, JoanOrfao, AlbertoRosinol, LauraMateos, Maria-VictoriaJose Lahuerta, JuanBlade, JoanSan-Miguel, Jesus F.Paiva, Bruno2025-01-072025-01-072018-11-290006-4971https://hdl.handle.net/10668/24471enClinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogeneticsconference output10.1182/blood-2018-99-1133121528-0020454837600166